6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Substance Use and Chronic Health Conditions
Substance use is intricately linked to chronic health conditions, significantly impacting physical and mental well-being. Prolonged substance abuse can lead to liver disease, cardiovascular problems, and respiratory issues, depending on the substance. Additionally, conditions like diabetes, hypertension, and chronic pain often coexist with substance use disorders, creating complex treatment challenges. The interplay between substance use and chronic illness requires integrated care that addresses both conditions simultaneously. Multidisciplinary approaches, including medication-assisted treatment (MAT), lifestyle interventions, and behavioral therapies, are essential. Educating patients about the bidirectional impact of substance use and chronic diseases can improve adherence to treatment plans and enhance overall health outcomes.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States